Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

被引：0
|
作者：
Moa Lugner
Naveed Sattar
Mervete Miftaraj
Jan Ekelund
Stefan Franzén
Ann-Marie Svensson
Björn Eliasson
机构：
[1] University of Gothenburg,Institute of Medicine
[2] Sahlgrenska University Hospital,Institute of Cardiovascular and Medical Sciences
[3] University of Glasgow,undefined
[4] National Diabetes Register,undefined
[5] Centre of Registers,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Type 2 diabetes; Epidemiology; Sodium glucose transporter 2 inhibitors; Glucagon‐like peptide-1 receptor agonist; Mortality; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] IMPACT OF GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Timkina, N.
    Simanenkova, A.
    Mart'Yanova, M.
    Karonova, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S460 - S460
  • [22] GLP-1 receptor agonists in comparison with SGLT-2 inhibitors
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (05): : 530 - 531
  • [23] Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes
    Neuen, Brendon L.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 709 - 711
  • [24] Type 1 diabetes: Prescription of GLP-1 receptor agonists and SGLT2 inhibitors
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2025, 20 (01) : 23 - 23
  • [25] Cardiovascular Effectiveness of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Routine Care of Frail People with Type 2 Diabetes
    Kutz, Alexander
    Gopalakrishnan, Chandrasekar
    Kim, Dae H.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [26] GLP-1 receptor agonists and SGLT-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
    Zheng, K.
    Azhie, A.
    You, X.
    Naghibzadeh, M.
    Tan, E.
    Naimimohasses, S.
    Sridhar, V.
    Gupta, S.
    Chen, S.
    Dash, S.
    Jaeckel, E.
    Woo, M.
    Singh, S.
    Cherney, D.
    Bhat, M.
    LIVER TRANSPLANTATION, 2024, 30 : 42 - 42
  • [27] Cardiovascular effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists in routine care of frail people with type 2 diabetes
    Kutz, A.
    Gopalakrishnan, C.
    Kim, D. H.
    Patorno, E.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S282 - S283
  • [28] Effects of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Heart Transplant Patients with Type 2 Diabetes: a Case Series
    Sammour, Yasser
    Nassif, Michael
    Thomas, Merrill
    Magwire, Melissa
    Khumri, Taiyeb
    Sperry, Brett
    Austin, Bethany
    Fendler, Timothy
    Kao, Andrew
    Vodnala, Deepthi
    Lawhorn, Stephanie
    Everley, Mark
    Magalski, Anthony
    Kosiborod, Mikhail
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S26 - S26
  • [29] SGLT2 Inhibitors or GLP-1 Receptor Agonists Reduce Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2021, 104 (02) : 206 - 206
  • [30] Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 26 - 28
12345